glp 1 peak Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Effects of GLP-1 and pegGLP-1
Description
Not Currently Part of U.S
Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects
They work by increasing insulin when glucose is high, reducing glucagon, slowing stomach emptying, and promoting a feeling of fullness 7
A clinical study involving 564 adults (BMI 30-40 kg/m2, without T2DM) found that compared with orlistat (3120 mg, weight loss of 4.1 kg), LIR (subcutaneous administration of 1.2 mg/d, 1.8 mg/d, 2.4 mg/d or 3 mg/d) had an average weight loss of 4.8-7.2 kg, the two-year extended experiment of which also showed similar results (88, 89)
HDL cholesterol tends to increase slightly
Attorneys are advocating for their clients, which means they have a vested interest in highlighting potential risks and adverse outcomes
